247 related articles for article (PubMed ID: 18503988)
1. Current and novel therapies in acute GVHD.
Ho VT; Cutler C
Best Pract Res Clin Haematol; 2008 Jun; 21(2):223-37. PubMed ID: 18503988
[TBL] [Abstract][Full Text] [Related]
2. [Novel progress on treatment of acute graft-versus-host disease].
Zhou Y; Chen BA; Zhao G
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):238-41. PubMed ID: 20137155
[TBL] [Abstract][Full Text] [Related]
3. Novel strategies for the treatment and diagnosis of graft-versus-host-disease.
Ferrara JL
Best Pract Res Clin Haematol; 2007 Mar; 20(1):91-7. PubMed ID: 17336259
[TBL] [Abstract][Full Text] [Related]
4. Graft-versus-host disease in allogeneic bone marrow transplantation: the role of monoclonal antibodies in prevention and treatment.
Hiscott A; McLellan DS
Br J Biomed Sci; 2000; 57(2):163-9. PubMed ID: 10912294
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow transplantation: new approaches to immunosuppression and management of acute graft-versus-host disease.
Auletta JJ; Cooke KR
Curr Opin Pediatr; 2009 Feb; 21(1):30-8. PubMed ID: 19242239
[TBL] [Abstract][Full Text] [Related]
6. Improved survival and preserved antiviral responses after combination therapy with daclizumab and infliximab in steroid-refractory graft-versus-host disease.
Rao K; Rao A; Karlsson H; Jagani M; Veys P; Amrolia PJ
J Pediatr Hematol Oncol; 2009 Jun; 31(6):456-61. PubMed ID: 19648797
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of patients treated with daclizumab for steroid-refractory acute graft-vs-host disease.
Perales MA; Ishill N; Lomazow WA; Weinstock DM; Papadopoulos EB; Dastigir H; Chiu M; Boulad F; Castro-Malaspina HR; Heller G; Jakubowski AA; O'Reilly RJ; Small TN; Young JW; Kernan NA
Bone Marrow Transplant; 2007 Sep; 40(5):481-6. PubMed ID: 17618322
[TBL] [Abstract][Full Text] [Related]
8. Treatment options in steroid-refractory acute graft-versus-host disease following hematopoietic stem cell transplantation.
Kim SS
Ann Pharmacother; 2007 Sep; 41(9):1436-44. PubMed ID: 17684033
[TBL] [Abstract][Full Text] [Related]
9. Infliximab treatment for steroid-refractory acute graft-versus-host disease.
Patriarca F; Sperotto A; Damiani D; Morreale G; Bonifazi F; Olivieri A; Ciceri F; Milone G; Cesaro S; Bandini G; Dini G; Corradini P; Fanin R
Haematologica; 2004 Nov; 89(11):1352-9. PubMed ID: 15531458
[TBL] [Abstract][Full Text] [Related]
10. Update on the management of acute graft-versus-host disease.
Bolaños-Meade J
Curr Opin Oncol; 2006 Mar; 18(2):120-5. PubMed ID: 16462179
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of rituximab in chronic graft-versus-host disease.
Bates JS; Engemann AM; Hammond JM
Ann Pharmacother; 2009 Feb; 43(2):316-21. PubMed ID: 19193571
[TBL] [Abstract][Full Text] [Related]
12. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
Liu QF; Fan ZP; Zhang Y; Jiang ZJ; Wang CY; Xu D; Sun J; Xiao Y; Tan H
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1376-85. PubMed ID: 19822296
[TBL] [Abstract][Full Text] [Related]
13. Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance.
Kline J; Subbiah S; Lazarus HM; van Besien K
Bone Marrow Transplant; 2008 Mar; 41(6):505-13. PubMed ID: 18026144
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of CD20 blockade in allogeneic hematopoietic cell transplantation.
Kharfan-Dabaja MA; Bazarbachi A
Biol Blood Marrow Transplant; 2010 Oct; 16(10):1347-54. PubMed ID: 20083213
[TBL] [Abstract][Full Text] [Related]
15. Prevention and treatment of acute GvHD.
Messina C; Faraci M; de Fazio V; Dini G; Calò MP; Calore E;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S65-70. PubMed ID: 18545247
[TBL] [Abstract][Full Text] [Related]
16. Infliximab treatment for steroid-refractory acute graft-versus-host disease after orthotopic liver transplantation: a case report.
Piton G; Larosa F; Minello A; Becker MC; Mantion G; Aubin F; Deconinck E; Hillon P; Di Martino V
Liver Transpl; 2009 Jul; 15(7):682-5. PubMed ID: 19562700
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis and treatment of acute graft-versus-host disease.
Chao NJ; Chen BJ
Semin Hematol; 2006 Jan; 43(1):32-41. PubMed ID: 16412787
[TBL] [Abstract][Full Text] [Related]
18. Graft-versus-host disease after allogeneic stem cell transplantation: evolving concepts and novel therapies including photopheresis.
Komanduri KV; Couriel D; Champlin RE
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):1-6. PubMed ID: 16399595
[TBL] [Abstract][Full Text] [Related]
19. Acute graft-versus-host disease in children.
Jacobsohn DA
Bone Marrow Transplant; 2008 Jan; 41(2):215-21. PubMed ID: 17934526
[TBL] [Abstract][Full Text] [Related]
20. Treatment of graft-versus-host disease with monoclonal antibodies and related fusion proteins.
Schroeder T; Haas R; Kobbe G
Expert Rev Hematol; 2010 Oct; 3(5):633-51. PubMed ID: 21083479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]